0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query ark patent intelligence metformin sitagliptin patent extension data exclusivity expiry snapsho 1.Your search for "" gave back 1493320 results.
The global Dipeptidyl Peptidase-4 Inhibitors market size is projected to grow from US$ 12520 million in 2022 to US$ 18380 million in 2029; it is...
Catalog:
LPI
April 2023
Price: USD 3,660.00
Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as...
Catalog:
IQ4I
May 2016
Price: USD 4,500.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
The global Metformin Hydrochloride market size was valued at USD 386.1 million in 2023 and is forecast to a readjusted size of USD 556 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Metformin Hydrochloride market size was valued at USD 386.1 million in 2022 and is forecast to a readjusted size of USD 556 million by...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect...
Catalog:
IQ4I
March 2021
Price: USD 4,950.00
A dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) is a type of medication used to treat type 2 diabetes. DPP-4 is an enzyme that breaks down the...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Dipeptidyl Peptidase-4 Inhibitors market size was valued at USD 13170 million in 2022 and is forecast to a readjusted size of USD 18780...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs. Also known as gliptins, they are usually prescribed for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The “Patent Licensing Industry Forecast” looks at past sales and reviews total world Patent Licensing sales in 2022, providing a comprehensive...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Patent Licensing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
GIR
January 2023
Price: USD 3,480.00
